Physician profile
Sadia Ejaz
NPI 1922481977
$18,966.51
in general payments reported to CMS, 2019-2025
63 companies · $4,953 in 2025
The $4,953 reported for 2025 was more than what 87% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.35 · 2020: $1,073 · 2021: $3,043 · 2022: $3,215 · 2023: $3,118 · 2024: $3,489 · 2025: $4,953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,739 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,739.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,820.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $2,856.77 | 2020-2025 | Korlym |
| Novo Nordisk INC | $2,721.29 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $1,810.75 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $1,730.10 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Xeris Pharmaceuticals, INC. | $676.64 | 2020-2024 | Gvoke Hypopen, Recorlev |
| Boehringer Ingelheim Pharmaceuticals, INC. | $579.01 | 2020-2025 | Jardiance, Synjardy |
| Amgen INC. | $562.06 | 2019-2025 | Tepezza, Evenity, Prolia |
| Insulet Corporation | $559.20 | 2021-2024 | Omnipod |
| Sanofi-Aventis U.S. LLC | $550.61 | 2020-2025 | |
| Abbvie INC. | $535.42 | 2020-2025 | |
| Dexcom, INC. | $450.31 | 2020-2025 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $417.69 | 2020-2024 | Nexletol |
| Radius Health, INC. | $409.56 | 2020-2025 | Tymlos |
| Antares Pharma, INC. | $394.53 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Ibsa Pharma INC. | $383.83 | 2021-2024 | Tirosint, Licart, Tirosint |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $344.67 | 2022-2025 | Cequr Simplicity |
| Mannkind Corporation | $315.84 | 2021-2025 | Afrezza |
| Amarin Pharma, INC. | $291.82 | 2020-2023 | |
| Medtronic, INC. | $281.37 | 2021-2025 | Minimed 780g, Inceptiv, Intellis Adaptivestim |
| Horizon Therapeutics Plc | $273.92 | 2019-2023 | Tepezza |
| Sequel Med Tech, LLC | $251.01 | 2025 | Twiist |
| Bayer Healthcare Pharmaceuticals INC. | $246.10 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $234.90 | 2020-2023 | Farxiga |
| Kowa Pharmaceuticals America, INC. | $169.98 | 2020-2022 | |
| Recordati_rare_diseases_inc. | $137.67 | 2022-2025 | Isturisa, Signifor Lar |
| Ascendis Pharma Endocrinology INC | $123.64 | 2025 | Yorvipath |
| Nestle Healthcare Nutrition INC. | $109.84 | 2020-2022 | |
| Beta Bionics, INC. | $98.69 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Medtronic Minimed, INC. | $86.73 | 2020 | |
| Halozyme INC | $82.49 | 2023 | |
| Amneal Pharmaceuticals LLC | $80.32 | 2022-2025 | Unithroid |
| Nevro Corp. | $78.83 | 2021-2024 | Senza |
| Neurocrine Biosciences, INC. | $74.79 | 2025 | |
| Lifescan, INC. | $66.99 | 2020-2022 | |
| Vivus LLC | $65.69 | 2023-2024 | Qsymia |
| Boston Scientific Corporation | $64.22 | 2022 | |
| Merck Sharp & Dohme LLC | $63.36 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $59.01 | 2023-2025 | |
| Rhythm Pharmaceuticals, INC. | $55.25 | 2025 | Imcivree |
| Pfizer INC. | $53.18 | 2022 | |
| Clarus Therapeutics INC. | $51.34 | 2021 | |
| Chiesi USA, INC. | $50.56 | 2025 | Mycapssa |
| Astellas Pharma US INC | $46.79 | 2023-2025 | Veozah, Myrbetriq |
| Currax Pharmaceuticals LLC | $44.73 | 2021-2022 | |
| Eusa Pharma (US) LLC | $32.45 | 2022 | |
| Azurity Pharmaceuticals, INC. | $31.68 | 2023 | Adthyza |
| Ultragenyx Pharmaceutical INC. | $30.92 | 2020-2023 | Crysvita |
| Acerus Pharmaceuticals Corporation | $30.53 | 2021 | |
| Almatica Pharma LLC | $30.19 | 2025 | Teriparatide |
| Eisai INC. | $28.56 | 2025 | |
| Aimmune Therapeutics, INC. | $26.29 | 2025 | Zenpep |
| Kyowa Kirin, INC. | $26.12 | 2024 | Crysvita |
| Alexion Pharmaceuticals, INC. | $23.72 | 2024 | Strensiq |
| Embecta Corp. | $21.78 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Regeneron Healthcare Solutions, INC. | $20.40 | 2025 | Evkeeza |
| Tandem Diabetes Care, INC. | $20.06 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Soleno Therapeutics, INC. | $19.80 | 2025 | Vykat Xr |
| Janssen Pharmaceuticals, INC | $15.75 | 2022 | |
| Endo Pharmaceuticals INC. | $15.61 | 2020 | |
| Optos, INC. | $14.26 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $12.99 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.24 | 2020 | |
| Zealand Pharma US, INC. | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sadia Ejaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.